Hormone therapy in prostatic cancer
Smith, P.H.; Akdas, A.; Mason, M.K.; Richards, B.; Robinson, M.R.; de Pauw, M.; Sylvester, R.
Acta Urologica Belgica 48(1): 98-105
1980
ISSN/ISBN: 0001-7183 PMID: 7001876 Document Number: 163236
Document emailed within 1 workday
Related Documents
Tsukamoto, T.; Fukui, I.; Kihara, K.; Goto, S.; Kitahara, S.; Kobayashi, T.; Kojima, S.; Oshima, H. 1996: Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy Hinyokika Kiyo. Acta Urologica Japonica 42(5): 351-356Machida, T.; Ikemoto, I. 1987: Hormone therapy of male genital cancer (prostatic cancer) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(10): 2845-2852
Kattan, J.; Court, B.; Culine, S.; Droz, J.P. 1993: False multiple coin lesions in prostatic cancer under hormone therapy Presse Medicale 22(23): 1104
Klosterhalfen, H. 1977: Hormone therapy of prostatic carcinoma Deutsche Medizinische Wochenschrift 102(25): 947
Studer, U.E. 1995: Advanced prostatic carcinoma--which hormone therapy when? Der Urologe. Ausg. a 34(5): 361-366
Haapiainen, R.; Rannikko, S.; Alfthan, O.; Adlercreutz, H. 1988: Pretreatment hormone levels in prostatic cancer Scandinavian Journal of Urology and Nephrology. Supplementum 110: 137-143
Stoter, G.; Jones, W.G. 1988: Chemotherapy of hormone refractory prostatic cancer Progress in Clinical and Biological Research 260: 123-125
Wemeau, L.; Mazeman, E.; Blanckaert, J.; Delhay, J. 1972: Results of hormone treatment of prostatic cancer. 168 cases Acta Urologica Belgica 40(1): 101-105
Ebert, T.; Bendhack, M.L. 1997: Prostatic carcinoma--diagnosis, hormone therapy, radio- and chemotherapy Der Urologe. Ausg. a 36(6): 570-577
Burk, K.; Schultze-Seemann, W.; Jonas, D.; Rodeck, G. 1989: Weekly epirubicin in patients with hormone refractory prostatic cancer--a two-year follow-up Progress in Clinical and Biological Research 303: 277-285
Eichenberger, T.; Trachtenberg, J.; Chronis, P.; Keating, A. 1989: Synergistic effect of ketoconazole and antineoplastic agents on hormone-independent prostatic cancer cells Clinical and Investigative Medicine. Medecine Clinique et Experimentale 12(6): 363-366
Matzkin, H.; Greenstein, A.; Kaver, I.; Braf, Z. 1989: Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience Israel Journal of Medical Sciences 25(7): 388-392
Bertelli, A. 1990: Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH Drugs under Experimental and Clinical Research 16(Suppl): 1-2
Gez, E.; Ben-Yosef, R.; Libson, E.; Biran, S. 1987: The use of agonist analogues of luteinizing hormone--releasing hormone in the treatment of prostatic carcinoma Harefuah 112(5): 239-241
Weissbach, L. 1992: Prospective randomized multicenter phase IIi study of treatment of hormone refractory prostatic cancer: mitomycin C vs. 4-epirubicin vs. estramustine phosphate Der Urologe. Ausg. a 31(1): 62
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Fujita, K. 1986: Progress in cancer therapy. 12. Prostatic cancer Nursing Technique 32(16): 2084-2087
Nozaki, H.; Funahashi, H.; Sato, Y.; Imai, T.; Oike, E.; Kato, M.; Takagi, H. 1991: Study of hormone replacement therapy following total thyroidectomy in thyroid cancer--with special reference to the analysis of thyroid hormone peripheral effects, using indirect calorimetry Nihon Geka Gakkai Zasshi 92(12): 1700-1707
1996: Current aspects in the therapy of prostatic cancer Der Urologe. Ausg. A 35(1 Suppl Aktuelle): 1-12